Condition

Breast Diseases

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 61 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials61

Recruiting8

Common interventions25

Lead sponsors shown15

Clinical trials

60 shown

Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI ModelsNCT07500428 · 2026-03-12

Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical StudyNCT07581834 · 2026-01-21

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.NCT06335069 · 2025-09-01

A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer PatientsNCT07010939 · 2025-04-07

A Study of Breast Cancer Risk Factors and Outcomes of People in FloridaNCT06780176 · 2025-01-13

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)NCT05465031 · 2024-04-17

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 StudyNCT06805812 · 2023-05-01

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerNCT05386108 · 2022-08-31

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsNCT07038369 · 2025-07-29

ACTIVE_NOT_RECRUITING

A Retrospective Real-world Study of Abemaciclib in HR+ Breast CancerNCT06341283 · 2024-06-01

Real World Evaluation of Lunit INSIGHT MMG TechnologyNCT06232070 · 2024-02-01

The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region ÖstergötlandNCT06187350 · 2023-08-01

Explore Association Models Between Environmental Hormones andBreast CancerNCT06765395 · 2023-03-20

ACTIVE_NOT_RECRUITING

Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline MutationNCT04711109 · 2023-02-14

ACTIVE_NOT_RECRUITING

Evaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES DescartesNCT05792475 · 2023-01-30

Vacuum-Assisted Evacuation (VAE) Of Symptomatic and/or Voluminous Breast Haematomas Following Surgeries And Percutaneous Procedures: a Retrospective AnalysisNCT05665894 · 2022-10-01

Lymphaticovenous Anastomosis as Treatment for LymphedemaNCT05441943 · 2022-05-11

ACTIVE_NOT_RECRUITING

Effectiveness and Safety of Preoperative Magnetic Detection of Non-palpable Breast LesionsNCT05327218 · 2022-03-20

Different Volumes of Erector Spinae Plane Block for Breast SurgeryNCT05232084 · 2022-01-27

Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense BreastsNCT04854304 · 2021-09-23

ACTIVE_NOT_RECRUITING

Contrast-Free Magnetic Resonance Imaging for Breast DiseaseNCT05006196 · 2021-07-06

ACTIVE_NOT_RECRUITING

Advanced Diffusion Tensor MRI for Breast CancerNCT04774471 · 2021-02-03

Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast SurgeryNCT04554316 · 2020-11-01

Diagnosis Predictive Modle for Dense Density Breast Tissue Based on RadiomicsNCT04535466 · 2020-09-01

Evaluation of TaiHao Breast Ultrasound Diagnosis SoftwareNCT04551105 · 2020-08-15

Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)NCT04341129 · 2020-07-13

Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast CancerNCT04605575 · 2020-05-22

Pectoral Nerve Block Type-II and Rhomboid Intercostal Block for Pain Management Following Mastectomy SurgeryNCT04297007 · 2020-03-23

Breast Ultrasonography and Polycystic Ovary SyndromeNCT04231786 · 2020-01-14

Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing MastectomyNCT04151368 · 2019-11-01

Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast CancerNCT04088110 · 2019-11-01

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast CancerNCT03756064 · 2019-08-01

Post Market Clinical Follow Up to "Patient Reported Outcome" Using a Titanised Polypropylene Mesh (TiLOOP® Bra Pocket)NCT03868514 · 2019-07-04

Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBCNCT03910712 · 2019-06-01

Leflunomide in Previously Treated Metastatic Triple Negative CancersNCT03709446 · 2019-04-16

The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast CancerNCT03756090 · 2018-12-01

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNANCT05814224 · 2018-05-22

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver MetastasesNCT03500380 · 2018-04-24

PET-MRI for Axillary Staging in Node Negative Breast Cancer PatientsNCT03374826 · 2018-02-22

Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic BreastNCT03304080 · 2017-12-20

ACTIVE_NOT_RECRUITING

Empowering Latinas to Obtain Breast Cancer ScreeningsNCT02964234 · 2017-03-01

Long Term Use of SAVI SCOUT: Pilot StudyNCT03015649 · 2017-02-03

Single-shot Pectoral Plane(PECs) Block Versus Continuous Local Anaesthetic Infusion Analgesia or Both PECS Block and Local Anaesthetic Infusion After Breast Surgery: A Prospective Randomised, Double-blind TrialNCT03024697 · 2017-01-01

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsNCT02909452 · 2016-09-20

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid TumorsNCT02897778 · 2016-08-24

Oncoplastic Approach to Excisional Breast BiopsiesNCT02452333 · 2015-05-01

Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)NCT02557906 · 2014-07-01

Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBCNCT01917279 · 2013-10-01

Botulinum Toxin A (Botox) in Tissue Expander Breast ReconstructionNCT01591746 · 2012-08-01

The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast ReconstructionNCT01427400 · 2011-10-01

A Randomized Controlled Comparative Study of Ultrasound-guided Paravertebral Blocks as Part of a Multimodal Regimen for Ambulatory Breast Cancer SurgeryNCT01654432 · 2011-07-01

Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast CancerNCT01299987 · 2011-01-01

Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant TherapyNCT01140776 · 2010-11-01

Clinical Evaluation of Tissue Sampling Bias in Histologic Evaluation of Sentinel Lymph Nodes in Breast CancerNCT01140763 · 2010-08-01

Clinical Evaluation of OSNA Breast Cancer System to Extensive Frozen Section HistopathologyNCT01368744 · 2010-03-01

Guarana (Paullinia Cupana) for Breast Cancer Chemotherapy-related FatigueNCT01043913 · 2008-02-01

Clinical Evaluation of OSNA Breast Cancer System to Test Sentinel Lymph Nodes From Patients With Breast CancerNCT01136369 · 2007-02-01

T3AI-Pain After Breast SurgeryNCT00299039 · 2006-05-01

Studying Normal Breast Tissue and Cancer RiskNCT00341692 · 2003-04-07

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast CancerNCT00050427 · 2002-12-01

Common interventions

Leading sponsors

Sysmex America, Inc.4 Maastricht University Medical Center2 Medipol University2 Peking Union Medical College Hospital2 Syndax Pharmaceuticals2 TaiHao Medical Inc.2 Zhejiang Cancer Hospital2 Abramson Cancer Center at Penn Medicine1 Akdeniz University1 Albert Einstein Healthcare Network1 Alliance for Clinical Trials in Oncology1 Atavistik Bio, Inc1 Binghe Xu1 BioNumerik Pharmaceuticals, Inc.1 Centro di Riferimento Oncologico - Aviano1

Trial status mix

COMPLETED27

UNKNOWN17

RECRUITING8

ACTIVE_NOT_RECRUITING7

SUSPENDED1

TERMINATED1

Phase mix

NA17

PHASE211

PHASE16

PHASE36

PHASE43

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.